Statements (34)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
opioid
|
| gptkbp:ATCCode |
N02AX06
|
| gptkbp:CASNumber |
27216-75-7
|
| gptkbp:chemicalFormula |
C15H21NO2
|
| gptkbp:combines |
gptkb:naloxone
|
| gptkbp:developedBy |
gptkb:Knoll_AG
|
| gptkbp:discoveredIn |
1970s
|
| gptkbp:eliminationHalfLife |
3-5 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Tilidin
|
| gptkbp:legalStatus |
controlled substance (Germany)
prescription only (Germany) |
| gptkbp:marketedIn |
gptkb:Germany
|
| gptkbp:metabolism |
nortilidine
|
| gptkbp:pregnancyCategory |
C (Germany)
|
| gptkbp:riskFactor |
addiction
abuse potential |
| gptkbp:routeOfAdministration |
oral
intramuscular intravenous rectal |
| gptkbp:sideEffect |
nausea
vomiting constipation dizziness respiratory depression euphoria |
| gptkbp:soldIn |
gptkb:United_States
|
| gptkbp:synonym |
gptkb:Tilidine
gptkb:Valoron |
| gptkbp:UNII |
6X9OC3H4II
|
| gptkbp:usedFor |
pain management
moderate to severe pain |
| gptkbp:bfsParent |
gptkb:Capital_Bra
|
| gptkbp:bfsLayer |
7
|